Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

CON vs BTSG: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CON Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 8–2 Matrix Metrics)

CON Overall Winner 6-Pillar Tally: CON 5 – 1 BTSG Matrix Metrics: CON 8 – 2 BTSG

As of Nov 20, 2026, Concentra Group Holdings Parent, Inc. (CON) is the stronger overall head-to-head candidate over BrightSpring Health Services, Inc. (BTSG) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). CON carries a Unified Composite Score of 43.5/100 (HOLD) at $41.84 (22.0x Forward P/E, 17.2% operating margin), whereas BTSG carries 42.6/100 (HOLD) at $62.84 (25.9x Forward P/E, 3.5% operating margin).

  • Growth vs. Quality Trade-Off: CON earns the overall head-to-head edge with a stronger Unified Composite Score (43.5/100 HOLD vs. BTSG 42.6/100 HOLD) and 0.52β · 38% Vol risk profile, whereas BTSG leads top-line expansion (+26.4% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CON vs BTSG
CON NYSE Head-to-Head Winner
Concentra Group Holdings Parent, Inc.
Services-Specialty Outpatient Facilities, Nec
$41.84
+0.94% 1D
Market Cap $5.2B
TTM Revenue $2.34B
Forward P/E 22.0x
Beta / 30D Vol 0.52β · 38% Vol
Unified Composite Score
43.5 / 100 HOLD
Tech 31.0 Fund 47.0 Flow 69.0 Mom 41.1
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (8.0% over 20 days), RSI 56
RSI-14: 55.6 · SMA20: $41.80 · SMA50: $38.66
BTSG NASDAQ
BrightSpring Health Services, Inc. Common Stock
Services-Home Health Care Services
$62.84
-1.84% 1D
Market Cap $12.7B
TTM Revenue $10.4B
Forward P/E 25.9x
Beta / 30D Vol 0.94β · 59% Vol
Unified Composite Score
42.6 / 100 HOLD
Tech 20.0 Fund 40.0 Flow 57.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 42
RSI-14: 42.1 · SMA20: $66.80 · SMA50: $62.62

6-Pillar Scorecard Institutional Category Breakdown (CON 5 – 1 BTSG)

Columns: Metric · CON · BTSG
1. Valuation Multiples CON
Forward P/E 22.0x 25.9x
Trailing P/E 24.5x 45.4x
PEG Ratio N/M N/M
EV / Revenue 3.1x 1.3x
2. Growth & Scale BTSG
Revenue Growth (YoY) +8.6% +26.4%
Earnings Growth (YoY) +36.4% +82.0%
TTM Revenue (USD) $2.34B $10.4B
Market Cap $5.2B $12.7B
3. Profitability & Quality CON
Gross Margin 29.9% 12.5%
Operating Margin 17.2% 3.5%
Net Profit Margin 9.3% 2.7%
Return on Equity (ROE) 47.2% 15.5%
4. Balance Sheet & Cash Flow CON
Cash Generation (TTM) $257M $337M
Cash Flow Margin 11.0% 3.2%
Net Cash / Leverage $2.04B Net Debt (4.20x D/E) $1.14B Net Debt (1.09x D/E)
Dividend Yield 0.60% None (0.00%)
5. Options & Positioning CON
Options Structure Phase BREAKOUT CONSOLIDATION
Current IV / %ile 269.9% (95th %ile) 152.7% (100th %ile)
Put/Call OI Skew 0.79x (Call-Skewed) 1.69x (Put-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Neutral
6. R&D & Supply-Chain Moat CON
OpEx & R&D Intensity 12.7% of Rev ($297M) 9.0% of Rev ($939M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Care Facilities Operator Health Information Services Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CON (8) vs BTSG (2)
Institutional Metric CON BTSG Criterion Row Edge
Market Capitalization
Scale
$5.2B $12.7B Larger Scale BTSG
Trailing P/E Ratio
Valuation
24.5x 45.4x Lower Multiple CON
Forward P/E Ratio
Valuation
22.0x 25.9x Lower Multiple CON
Revenue Growth (YoY)
Growth
+8.6% +26.4% Higher Growth BTSG
Operating Margin (TTM)
Profitability
17.2% 3.5% Higher Margin CON
Net Profit Margin
Profitability
9.3% 2.7% Higher Margin CON
Return on Equity (ROE)
Capital Efficiency
47.2% 15.5% Higher ROE CON
52-Week Range Position
Momentum
91% ($19–$44) 74% ($31–$74) Stronger Trend CON
Beta / 30D Volatility
Risk Regime
0.52β · 38% Vol 0.94β · 59% Vol Lower Realized Risk CON
Unified Institutional Score
Composite Signal
43.5 / 100 (HOLD) 42.6 / 100 (HOLD) Higher Composite CON
Trailing 12M Revenue (USD)
Operating Scale
$2.34B $10.4B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
29.9% 12.5% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 3.1x EV/Rev N/M PEG · 1.3x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$257M ($2.04B Net Debt (4.20x D/E)) $337M ($1.14B Net Debt (1.09x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CON +1.43 pp
CON: +4.68% · BTSG: +3.25%
3M Horizon CON +13.95 pp
CON: +19.58% · BTSG: +5.63%
6M Horizon CON +57.82 pp
CON: +65.24% · BTSG: +7.42%
1Y Horizon CON +22.79 pp
CON: +117.58% · BTSG: +94.79%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period CON Revenue BTSG Revenue CON Op. Margin BTSG Op. Margin Margin Leader
FY2022 $1.72B $7.72B 15.0% 2.4% CON
FY2023 $1.84B $7.69B 15.6% 0.8% CON
FY2024 $1.90B $10.1B 16.0% 1.1% CON
FY2025 $2.16B $12.9B 15.4% 2.3% CON

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CON BREAKOUT
99d in phase · OBV NEUTRAL
Current IV 269.9%
IV Percentile 95th %ile
Put/Call OI Skew 0.79x (Call-Skewed)
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact CON Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
BTSG CONSOLIDATION
104d in phase · OBV NEUTRAL
Current IV 152.7%
IV Percentile 100th %ile
Put/Call OI Skew 1.69x (Put-Skewed)
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow NEUTRAL
Exact BTSG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $69.67 · IV 45.1%

BTSG Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($6,967)

Compare $6,967 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 45.1% ATM IV.

5-DAY BULLISH SWING Liq B

Dec 18 $70 / $75 Bull Call Spread

Buy 1x $70C · Sell 1x $75C · 31d

Net Entry $253 Debit
T+5d @ +5% Move +$58 (+23%)
Max Risk / Buffer $253 Capped
5d Edge & Liquidity 0.7x R:R · Liq B
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq C

Jan 15 '27 $65 / $60 Bull Put Spread

Sell 1x $65P · Buy 1x $60P · 59d

Net Entry $70 Credit
Max Credit / Yield +$70 (+16.3% RoM)
Max Risk / Buffer -7.7% Cushion ($430 Mgn)
5d Edge & Liquidity 72% PoP · Liq C
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CON Moat Profile High-Margin Pricing Power Moat
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $5.2B market capitalization and 17.2% operating margin.
OpEx & R&D Reinvestment 12.7% of Rev ($297M)
90D Engineering Disclosures 0 Published
BTSG Moat Profile Cyclical / Execution-Driven Positioning
Health Information Services Operator
Competes within the Health Information Services value chain with $12.7B market capitalization and 3.5% operating margin.
OpEx & R&D Reinvestment 9.0% of Rev ($939M)
90D Engineering Disclosures 0 Published

Investor FAQ CON vs BTSG Key Questions & Quantitative Answers

As of Nov 20, 2026, Concentra Group Holdings Parent, Inc. (CON) is the stronger overall head-to-head candidate over BrightSpring Health Services, Inc. (BTSG) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). CON carries a Unified Composite Score of 43.5/100 (HOLD) at $41.84 (22.0x Forward P/E, 17.2% operating margin), whereas BTSG carries 42.6/100 (HOLD) at $62.84 (25.9x Forward P/E, 3.5% operating margin). Growth vs. Quality Trade-Off: CON earns the overall head-to-head edge with a stronger Unified Composite Score (43.5/100 HOLD vs. BTSG 42.6/100 HOLD) and 0.52β · 38% Vol risk profile, whereas BTSG leads top-line expansion (+26.4% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.

BTSG leads the Growth & Scale pillar: CON posts +8.6% YoY revenue growth and +36.4% YoY earnings growth on $2.34B TTM revenue (29.9% gross margin, 17.2% operating margin), compared with BTSG at +26.4% YoY revenue growth and +82.0% YoY earnings growth on $10.4B TTM revenue (12.5% gross margin, 3.5% operating margin). Across the 4-period historical trajectory (FY2022 to FY2025), CON cumulative revenue shifted +25.6% while BTSG shifted +67.2%. In operating R&D and SG&A reinvestment, CON deploys 12.7% of Rev ($297M) (0 90-day corporate R&D disclosures) versus 9.0% of Rev ($939M) (0 disclosures) for BTSG.

CON screens cheaper on headline valuation multiples. CON trades at 22.0x Forward P/E, 24.5x Trailing P/E, N/M PEG, and 3.1x EV/Revenue (11.0% FCF margin), whereas BTSG trades at 25.9x Forward P/E, 45.4x Trailing P/E, N/M PEG, and 1.3x EV/Revenue (3.2% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CON (47.2% ROE) versus BTSG (15.5% ROE) capital efficiency.

In options market volatility and institutional positioning, CON carries 269.9% implied volatility (95th %ile, Extreme (>80th %ile)), a 0.79x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKOUT options structure phase (0.52β · 38% Vol realized risk). By comparison, BTSG carries 152.7% implied volatility (100th %ile, Extreme (>80th %ile)), a 1.69x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.94β · 59% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.